Design and Validation of an Automated Process for the Expansion of Peripheral Blood‐Derived CD34 + Cells for Clinical Use After Myocardial Infarction
Stem cells translational medicine - United States
doi 10.1002/sctm.17-0277
Full Text
Open PDFAbstract
Available in full text
Date
April 29, 2019
Authors
Publisher
Wiley